Publication:
Lorlatinib in ALK- or ROS1-Positive Non-Small Cell Lung Cancer Patients: Experience from an Early Access Program in Turkey

Thumbnail Image

Files

file.pdf (419.92 KB)

Date

2019-10

Authors

Journal Title

Journal ISSN

Volume Title

Publisher

ELSEVIER SCIENCE INC

Research Projects

Organizational Units

Journal Issue

Abstract

Description

Keywords

ALK positive, ROS1 positive, Lorlatinib, Advanced stage lung cancer

Citation

URI

https://hdl.handle.net/11424/246077

Collections

Araştırma Çıktıları

Endorsement

Review

Supplemented By

Referenced By